Ralph Tripp

Has grant

Professor and Georgia Research Alliance Chair

University of Georgia

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ralph Tripp is a Professor and Georgia Research Alliance Chair at the University of Georgia, USA. His research focuses on antiviral agents, particularly against respiratory viruses, and includes studies on the immunogenicity of vaccine candidates and the modulation of cellular responses to viral infections. Recent publications highlight his work on probenecid’s effects on virus replication and immune response mechanisms, as well as advancements in mRNA vaccine technology for influenza.

Recent Grants

Grant: Close

SERS Based Micro-Sensor Arrays for Quantitative miRNAs Detection

Open Date: 2011-09-01

Close Date: 2014-08-31

Grant: Close

RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload

Open Date: 2010-04-01

Close Date: 2015-03-31

Grant: Close

Immunobiology of Influenza Virus Infection: Approaches for an Emerging Zoonotic D

Open Date: 2007-06-15

Close Date: 2008-05-31

Grant: Close

Antibody inhibition of respiratory syncytial virus G protein activity

Open Date: 2007-01-15

Close Date: 2010-12-31

Grant: Close

MECHANISMS OF CYTOTOXIC T CELL SPECIFICTY TO ADENOVIRUS

Open Date: 1992-10-01

Close Date:

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Luis Martinez-Sobrido

Professor

Texas Biomedical Research Institute

UNITED STATES

View details

Rebecca DuBois

Professor

University of California, Santa Cruz

UNITED STATES

View details

Larry Anderson

Professor

Emory University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ralph Tripp

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Restricting O-Linked Glycosylation of the Mucin-like Domains Enhances Immunogenicity and Protective Efficacy of a Respiratory Syncytial Virus G Glycoprotein Vaccine Antigen

Layer-by-Layer Microparticle Vaccines Containing a S177Q Point Mutation in the Central Conserved Domain of the RSV G Protein Improves Immunogenicity.

Evaluating Probenecid or Oseltamivir Inhibition of Influenza A Virus Replication Through Plaque Assay or Fluorescent Focus Assay Using Non-Structural Protein 1–H1N1 Venus Reporter Virus

The MAPK Response to Virus Infection Is Modified by Probenecid

Probenecid Inhibits NLRP3 Inflammasome Activity and Mitogen-Activated Protein Kinases (MAPKs)

Probenecid Inhibits Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus Response

Antiviral agents and therapeutics against respiratory viruses

Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice

mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge

Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein

Interferons—Implications in the Immune Response to Respiratory Viruses

Oral Probenecid for Nonhospitalized Adults with Symptomatic Mild-to-Moderate COVID-19

Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein

Influenza B Virus (IBV) Immune-Mediated Disease in C57BL/6 Mice

Isothermal amplification using sequence-specific fluorescence detection of SARS coronavirus 2 and variants in nasal swabs

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication

Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)

Collaborators (3)

Luis Martinez-Sobrido

Rebecca DuBois

Larry Anderson

Make your next move.